The Brazilian drug law in force since 2006 provides that the Union may authorize the planting, cultivation, harvesting and exploitation of any plant, exclusively, for medicinal or scientific purposes, subject to supervision. However, to date, the Union has not yet created a regulatory model for such authorizations for the cultivation and processing of the Cannabis Sativa plant. Thus, Brazil began the process of legalizing Cannabis and hemp for therapeutic and medicinal purposes only in 2014, with the release of the country's health surveillance for the import of cannabinoid-based medicines. However, even with the slowness of the Brazilian regulatory process, this industry has already reached the mark of approximately 200 million reais in revenue by 2021, including all current forms of regulation.

 

For you to understand how all this will work in practice, we have prepared a compilation of information so that you are aware of the subject and can be part of the international Cannabis market with quality.